ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors

ReciBioPharm partners with GeneVentiv Therapeutics to advance first AAV-based gene therapy for haemophilia patients

Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology

SPT Labtech to co-market streamlined NGS library preparation workflows for both PCR and PCR-free applications with Roche

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

DNAnexus Adds NVIDIA NIM and CUDA-X Microservices to Precision Health Data Cloud to Accelerate Drug Discovery and Improve Patient Care

DNAnexus is integrating new NVIDIA NIM and CUDA-X microservices to its Precision Health Data Cloud.

Bio-IT World: Venture, Innovation & Partnering Conference to Debut in Boston, Concurrent with 23rd Annual Bio-IT World Conference & Expo

Cambridge Healthtech Institute announces the final agenda for the inaugural Bio-IT World: Venture, Innovation & Partnering Conference—a gathering of leading investors, executives, research institutions, biotech and informatics innovators, startups, and strategics whose creative partnerships are catalyzing today’s drug discoveries. The April 17 Boston event, drawing heavily from leaders within the renowned Boston/Cambridge, Mass. biotech community, will be part of the 23rd annual Bio-IT World Conference & Expo April 15-17, which will attract more than 3,000 life science and IT innovators.

AbbVie Launches Phase I Clinical Trial for ABBV-1882, Promising HIV Drugs Treatment Approach

The initiation of the phase I clinical trial for ABBV-1882 marks a significant milestone in the quest for novel HIV treatments. With its unique mechanism of action and potential to transform HIV management, ABBV-1882 represents a beacon of hope for individuals living with HIV and underscores AbbVie's unwavering commitment to advancing science for the benefit of patients worldwide.

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Bioforum Expands Leadership Team with Appointment of Michael Goedde as President

Life Sciences Industry Veteran to Lead Development and Execution of Growth and Innovation Strategy, Expanding Global Reach of Bioforum’s Biometric Services and Solutions

Quotient Sciences Strengthens Its Top Team with Three New Appointments

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

New Paper from Insilico Medicine Demonstrates Validity of AI Drug Discovery

Now, for the first time, a new paper in Nature Biotechnology from clinical stage AI-driven biotechnology company Insilico Medicine reveals the entire process behind the company’s lead AI-designed molecule for an AI-discovered target for the chronic, progressive and often fatal rare lung disease idiopathic pulmonary fibrosis (IPF), which impacts 5 million people worldwide.

Veramed appoints Karen Curran as Chief Strategy Officer

Specialist Biometrics CRO, Veramed has announced the appointment of Karen Curran as Chief Strategy Officer.

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

Clearwater Introduces IRM|Performance to Power Cybersecurity Maturity and Resiliency

Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX

Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for online purchase in Canada, Europe, South Korea and the U.S. through BIO INX, a pioneering developer and distributor of materials for 3D bioprinting.